TD Cowen Starts Reata Pharmaceuticals (RETA) at Outperform, 'We expect this to be one of the better new drug launches'
Tweet Send to a Friend
(Updated - July 6, 2023 6:12 AM EDT)
TD Cowen analyst Tyler Van Buren initiates coverage on Reata Pharmaceuticals ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
TD Cowen analyst Tyler Van Buren initiates coverage on Reata Pharmaceuticals ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
